RIBOONCOSTAR Trademark

Trademark Overview

On Friday, November 10, 2023, a trademark application was filed for RIBOONCOSTAR with the United States Patent and Trademark Office. The USPTO has given the RIBOONCOSTAR trademark a serial number of 79386745. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, July 10, 2024. This trademark is owned by Suzhou Ribo Life Science Co., Ltd.. The RIBOONCOSTAR trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Medicines for human purposes; crude drugs; pharmaceutical preparations; chemico-pharmaceutical preparations; biological preparations for medical purposes; chemical preparations for pharmaceutical purposes; chemical preparations for medical purposes; drugs for medical purposes; diagnostic preparations for medical purposes; potassium salts for medical purposes; sodium salts for medical purposes; pharmaceuticals for the treatment of cancer; anti-cancer preparations; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for the prevention and treatment of cancer; tumor suppressing agents; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the central nervous system; pharmaceuticals for the treatment of infectious diseases; pharmaceutical preparations for the treatment of hypercholesteremia; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical p...

Technological research; development of pharmaceutical preparations and medicines; pharmaceutical product evaluation; pharmaceutical research and development services; research in the field of pharmaceuticals; scientific research; chemical research and analysis; development and testing of chemical production methods; biochemical research and analysis; development of pharmaceutical preparations and medicines; clinical trials; medical research; testing of pharmaceuticals; industrial design
ribooncostar

General Information

Serial Number79386745
Word MarkRIBOONCOSTAR
Filing DateFriday, November 10, 2023
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, July 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedicines for human purposes; crude drugs; pharmaceutical preparations; chemico-pharmaceutical preparations; biological preparations for medical purposes; chemical preparations for pharmaceutical purposes; chemical preparations for medical purposes; drugs for medical purposes; diagnostic preparations for medical purposes; potassium salts for medical purposes; sodium salts for medical purposes; pharmaceuticals for the treatment of cancer; anti-cancer preparations; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for the prevention and treatment of cancer; tumor suppressing agents; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the central nervous system; pharmaceuticals for the treatment of infectious diseases; pharmaceutical preparations for the treatment of hypercholesteremia; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for treating diabetes; pharmaceutical agents affecting metabolism; anticoagulants; cardiovascular pharmaceuticals; pharmaceutical preparations for ocular or intraocular surgery; dietetic substances adapted for medical use; depuratives; medicines for veterinary purposes; pesticides; dressings, medical; composite materials for dental purposes; diapers for pets
Pseudo MarkRIBO ONCO STAR
Goods and ServicesTechnological research; development of pharmaceutical preparations and medicines; pharmaceutical product evaluation; pharmaceutical research and development services; research in the field of pharmaceuticals; scientific research; chemical research and analysis; development and testing of chemical production methods; biochemical research and analysis; development of pharmaceutical preparations and medicines; clinical trials; medical research; testing of pharmaceuticals; industrial design

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 5, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 5, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSuzhou Ribo Life Science Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCN

Trademark Events

Event DateEvent Description
Tuesday, January 9, 2024APPLICATION FILING RECEIPT MAILED
Tuesday, June 18, 2024ASSIGNED TO EXAMINER
Thursday, June 20, 2024NON-FINAL ACTION WRITTEN
Friday, June 21, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, July 10, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, January 4, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, January 5, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 10, 2024REFUSAL PROCESSED BY MPU
Sunday, July 28, 2024REFUSAL PROCESSED BY IB

Related Keywords

ribooncostar preparations pharmaceutical purposes research medical treatment chemical cancer development pharmaceuticals